NicOx Gets Positive Results In Second Phase III Trial For Naproxcinod
This article was originally published in The Pink Sheet Daily
Executive Summary
In addition to meeting clinical endpoints, anti-inflammatory continues to show non-detrimental effect on blood pressure.